MIT Alumni Taris Biomedical Nabs $15M VC Investment to Develop Drug-Delivery Tech

Taris is the latest MIT spinout to attract significant VC cash after receiving early-stage proof-of-concept funding from the school's Deshpande Center, further highlighting the center's ability to speed commercialization of MIT biomedical research.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.